Animalcare Group Plc (ANCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Animalcare Group Plc (ANCR) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX6.12 Million ≈ $744.51 USD) by net assets (GBX114.54 Million ≈ $13.94K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ANCR company net worth for the company's overall valuation and market capitalisation.
Animalcare Group Plc - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Animalcare Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Animalcare Group Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Animalcare Group Plc ranked by their cash flow conversion efficiency. Explore Animalcare Group Plc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
P/F Atlantic Petroleum
CO:ATLA-DKK
|
0.006x |
|
B P Marsh and Partners PLC
LSE:BPM
|
-0.015x |
|
AH-Vest Limited
JSE:AHL
|
-0.211x |
|
Falcon Gold Corp
V:FG
|
-0.004x |
|
ICZOOM Group Inc. Class A Ordinary Shares
NASDAQ:IZM
|
0.083x |
|
Baillie Gifford UK Growth Fund PLC
LSE:BGUK
|
0.007x |
|
Genprex Inc
NASDAQ:GNPX
|
-0.347x |
|
Goenka Diamond and Jewels Limited
NSE:GOENKA
|
0.000x |
Annual Cash Flow Conversion Efficiency for Animalcare Group Plc (2005–2025)
The table below shows the annual cash flow conversion efficiency of Animalcare Group Plc from 2005 to 2025. View Animalcare Group Plc (ANCR) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX114.54 Million ≈ $13.94K |
GBX10.92 Million ≈ $1.33K |
0.095x | -9.50% |
| 2024-12-31 | GBX113.31 Million ≈ $13.79K |
GBX11.93 Million ≈ $1.45K |
0.105x | -20.21% |
| 2023-12-31 | GBX77.89 Million ≈ $9.48K |
GBX10.28 Million ≈ $1.25K |
0.132x | +10.56% |
| 2022-12-31 | GBX78.99 Million ≈ $9.61K |
GBX9.43 Million ≈ $1.15K |
0.119x | -32.92% |
| 2021-12-31 | GBX78.80 Million ≈ $9.59K |
GBX14.02 Million ≈ $1.71K |
0.178x | +30.61% |
| 2020-12-31 | GBX81.59 Million ≈ $9.93K |
GBX11.12 Million ≈ $1.35K |
0.136x | -14.87% |
| 2019-12-31 | GBX81.89 Million ≈ $9.96K |
GBX13.11 Million ≈ $1.59K |
0.160x | +86.52% |
| 2018-12-31 | GBX86.59 Million ≈ $10.54K |
GBX7.43 Million ≈ $904.02 |
0.086x | +305.48% |
| 2017-12-31 | GBX89.64 Million ≈ $10.91K |
GBX1.90 Million ≈ $230.81 |
0.021x | -79.16% |
| 2017-06-30 | GBX23.84 Million ≈ $2.90K |
GBX2.42 Million ≈ $294.57 |
0.102x | -44.73% |
| 2016-06-30 | GBX22.52 Million ≈ $2.74K |
GBX4.14 Million ≈ $503.23 |
0.184x | -0.92% |
| 2015-06-30 | GBX20.99 Million ≈ $2.55K |
GBX3.89 Million ≈ $473.54 |
0.185x | +238.04% |
| 2014-06-30 | GBX19.45 Million ≈ $2.37K |
GBX1.07 Million ≈ $129.82 |
0.055x | -65.20% |
| 2013-06-30 | GBX17.96 Million ≈ $2.19K |
GBX2.83 Million ≈ $344.45 |
0.158x | +25.00% |
| 2012-06-30 | GBX16.84 Million ≈ $2.05K |
GBX2.12 Million ≈ $258.31 |
0.126x | -7.19% |
| 2011-06-30 | GBX15.79 Million ≈ $1.92K |
GBX2.15 Million ≈ $260.98 |
0.136x | -1.19% |
| 2010-06-30 | GBX14.08 Million ≈ $1.71K |
GBX1.94 Million ≈ $235.56 |
0.137x | -13.08% |
| 2009-06-30 | GBX15.38 Million ≈ $1.87K |
GBX2.43 Million ≈ $296.03 |
0.158x | +61.42% |
| 2008-06-30 | GBX14.64 Million ≈ $1.78K |
GBX1.44 Million ≈ $174.60 |
0.098x | -38.89% |
| 2007-06-30 | GBX6.14 Million ≈ $746.70 |
GBX984.00K ≈ $119.72 |
0.160x | +44.40% |
| 2006-06-30 | GBX5.82 Million ≈ $707.88 |
GBX646.00K ≈ $78.60 |
0.111x | +215.62% |
| 2005-06-30 | GBX5.68 Million ≈ $691.70 |
GBX200.00K ≈ $24.33 |
0.035x | -- |
About Animalcare Group Plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in… Read more